PATENT CLAIM ANALYSIS

Application Number: 15968355
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "562000"]

Abstract:
The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E 2 .

Claim (Index 9):
The method of  claim 1 , wherein the brain injury is a stroke.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 93.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15111144', '15147484', '15725950', '14414669', '11399033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7599400366007647
- 35 USC 102 Novelty (BERT): 0.4736685246013936
- Combined Prediction Score: 0.7313128854008276
- Mean Citation Score: 155.48370400000005
- Max Citation Score: 156.36563
- Similarity Product: 115.31911342218936

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test